Tadashi Ashizawa

发表

YKL-40 downregulation is a key factor to overcome temozolomide resistance in a glioblastoma cell line.

Akira Iizuka, Masaru Komiyama, Koichi Mitsuya, 2014, Oncology reports.

Identification of a New Series of STAT3 Inhibitors by Virtual Screening.

Kenji Matsuno, Masami Otsuka, Hidee Ishii, 2010, ACS medicinal chemistry letters.

Effect of the STAT3 inhibitor STX-0119 on the proliferation of a temozolomide-resistant glioblastoma cell line.

Akira Iizuka, Masaru Komiyama, Koichi Mitsuya, 2014, International journal of oncology.